These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37115050)

  • 21. Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma.
    Qi L; Jiang K; Zhao FF; Ren P; Wang L
    Sci Rep; 2024 Jan; 14(1):577. PubMed ID: 38182638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of DHX33 in promoting Warburg effect via regulation of glycolytic genes.
    Peng C; Hou ST; Deng CX; Zhang Y
    J Cell Physiol; 2021 Feb; 236(2):981-996. PubMed ID: 32617965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 24. The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.
    Wang H; Yu J; Wang X; Zhang Y
    Cell Signal; 2019 Feb; 54():170-178. PubMed ID: 30552990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DHX33 Recruits Gadd45a To Cause DNA Demethylation and Regulates a Subset of Gene Transcription.
    Feng W; Chen S; Wang J; Wang X; Chen H; Ning W; Zhang Y
    Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32312884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.
    Mitoma H; Hanabuchi S; Kim T; Bao M; Zhang Z; Sugimoto N; Liu YJ
    Immunity; 2013 Jul; 39(1):123-35. PubMed ID: 23871209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of ACKR1 predicts a good prognosis and suppresses sarcoma cell progression via regulating the tumor immune microenvironment.
    Lin J; Liang F; Zheng L; Zeng J; Lin J
    J Appl Genet; 2024 Feb; 65(1):121-136. PubMed ID: 38006471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 33. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of small molecule inhibitors targeting RNA helicase DHX33 as anti-cancer agents.
    Wang Y; Nie G; Wang X; Ge W; Zhang Y
    Bioorg Med Chem Lett; 2023 Nov; 96():129505. PubMed ID: 37838340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma.
    Xu T; Dai T; Zeng P; Song Q; He K; Hu Z; Li Y; Li Z
    Transl Cancer Res; 2021 Aug; 10(8):3811-3828. PubMed ID: 35116680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
    Zhou Z; Lin Z; Wang M; Wang L; Ji Y; Yang J; Yang Y; Zhu G; Liu T
    Eur J Med Res; 2024 Jan; 29(1):12. PubMed ID: 38173048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
    Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
    Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
    [No Abstract]   [Full Text] [Related]  

  • 40. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.